Navigation Links
Qforma Appoints New Member to Board of Directors
Date:5/6/2011

SANTA FE, N.M., May 6, 2011 /PRNewswire/ -- Qforma, the leading provider of advanced analytics and predictive modeling technologies for the health sciences industry, announced today the appointment of Mark Spiers to its Board of Directors. Spiers retired in April as President and CEO of Wolters Kluwer Pharma Solutions.

"Qforma is excited to welcome Mark, a highly respected, long-time leader in the pharmaceutical industry, to our Board," said Kelly Myers, Co-Founder and Chief Executive Officer of Qforma. "Mark has an immensely successful track record of leadership and results in U.S. and international pharmaceutical sales, marketing and managed care activities as well as healthcare data analytics. We look forward to the valuable insight and guidance Mark will provide."

Spiers brings to the Qforma Board of Directors nearly 30 years of industry experience marked by positions of increasing responsibility and executive leadership at Bristol-Myers Squibb Company (BMS), Pharmacia Corporation and MedPointe Pharmaceuticals.  Spiers joined Wolters Kluwer Health in 2007. As President and CEO of the Pharma Solutions division, he was responsible for all global business strategy and operations for the Company's healthcare analytics and marketing/publishing services product lines. He holds a BA from Austin College in Sherman, Texas.

"Qforma has broken new ground in such areas as physician social networking and helping their customers adapt to and capitalize on the changing commercial model in pharmaceutical, biotech and device sales and marketing," said Mark Spiers. "I look forward to serving on the Board and supporting Qforma's ongoing mission to provide game-changing analytic solutions to some of the industry's most challenging issues."

About Qforma

Qforma is the leading provider of advanced analytics and predictive modeling for the health sciences industry. The company leverages the talents of health sciences executives, physicists, mathematicians and programmers, to deliver actionable insights from large disparate data.  Qforma provides powerful sales, marketing and managed care contracting tools, including physician social network solutions, to help its clients realize significant resource efficiencies.

Media Contacts:
Lisa Haley, Qforma
(505) 989-3558
lhaley@qforma.com

Jeff Hoyak, MCS Healthcare Public Relations
(800) 477-9626, ext. 312
jeffh@mcspr.com


'/>"/>
SOURCE Qforma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Qforma Appoints Erin McLaughlin as Director, Field Operations
2. Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments
3. Qforma Appoints Two New Executives
4. PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. West Pharmaceutical Services, Inc. Appoints New Director
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Curemark Appoints Preeminent Pediatrics Gastroenterologist
9. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
10. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
11. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ... and patients about the safety issues related to dental restorations. According to the American ... projected to reach $6.4 billion in 2018 with more than 30 million Americans missing ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
Breaking Medicine News(10 mins):